Vor Biopharma

VOR · NASDAQ

$19.03+$0.99 (+5.49%)TodayMarket closed ·
Prev close $18.04

Who owns VOR

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 65.4% of VOR’s shares.

  • TCG Crossover Management, LLC10.5%
  • Fidelity Management & Research Company LLC8.8%
  • RA Capital Management, LP8.3%
  • Forbion Capital Partners7.6%
  • Next 6 largest institutions30.2%
  • All other shareholders34.6%
Top institutional holders of VOR
HolderShares% of shares
TCG Crossover Management, LLC5.67M10.47%
Fidelity Management & Research Company LLC4.75M8.76%
RA Capital Management, LP4.50M8.31%
Forbion Capital Partners4.12M7.60%
Verve Capital Ltd3.14M5.80%
VR Adviser, LLC3.04M5.61%
BlackRock Institutional Trust Company, N.A.2.95M5.44%
State Street Investment Management (US)2.62M4.83%
Frazier Life Sciences Management, L.P.2.54M4.69%
Vanguard Capital Management, LLC2.08M3.85%

Largest mutual fund holders

Top mutual fund holders of VOR
HolderShares% of shares
State Street SPDR S&P Biotech ETF1.85M3.42%
Vanguard Total Stock Market Index Fund1.55M2.86%
Fidelity Select Biotechnology Portfolio1.40M2.58%
Fidelity Small Cap Growth Fund1.27M2.34%
iShares Russell 2000 ETF1.05M1.94%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $5.32M (3 trades) of VOR on the open market, with no buys.

Latest VOR insider transactions
InsiderTypeSharesValue
RA CAPITAL MANAGEMENT, L.P.Option exercise500—
RA CAPITAL MANAGEMENT, L.P.Option exercise500$6.40K
RA CAPITAL MANAGEMENT, L.P.Option exercise1.50K—
RA CAPITAL MANAGEMENT, L.P.Option exercise1.50K$5.60K
RA CAPITAL MANAGEMENT, L.P.Option exercise2.10M$10.50M
RA CAPITAL MANAGEMENT, L.P.Sale213$4.21K
RA CAPITAL MANAGEMENT, L.P.Option exercise2.10M$4.20K
ZACCARDELLI DAVIDAward42.66K—
Joustra WouterAward57.16K—
Levin Andrew DavidAward57.16K—

Short interest

Settled Sep 30, 2026

Shares short
7.81M
Days to cover
4.34
% of shares outstanding
14.42%
Average daily volume
1.80M
Change since last report
−1.1%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.